SR One Capital Management, LP
Redwood City, CA · CIK 1910264 · 13F filing filed 2025-08-14
SEC-registered investment adviser since 2020 · limited partnership
- Assets managed$2.4bn
- Staff28 · 15 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds19 · $2.4bn gross assets
- Websitesrone.com
- Form ADV · 2026-03-31SEC adviser record
$461.4m
reported value
+18.5% vs Q1 2025
13positions
97.7%in top 10
1 new
0 added
0 reduced
0 sold out
vs Q1 2025
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARCELLX INC ACLX | $154.5m33.49% | Unchanged |
| ARS PHARMACEUTICALS INC SPRY | $70.0m15.18% | Unchanged |
| CRISPR THERAPEUTICS AG CRSP | $51.0m11.06% | Unchanged |
| ZENAS BIOPHARMA INC ZBIO | $47.6m10.32% | Unchanged |
| ORIC PHARMACEUTICALS INC ORIC | $45.8m9.93% | New |
| MINERALYS THERAPEUTICS INC MLYS | $42.3m9.17% | Unchanged |
| DESIGN THERAPEUTICS INC DSGN | $22.0m4.77% | Unchanged |
| OCULIS HOLDING AG OCS | $6.3m1.36% | Unchanged |
| ALUMIS INC ALMS | $5.9m1.27% | Unchanged |
| NKARTA INC NKTX | $5.5m1.20% | Unchanged |
| ORUKA THERAPEUTICS INC ORKA | $4.8m1.05% | Unchanged |
| KALA BIO INC COM NEW | $2.9m0.62% | Unchanged |
| ENGENE HOLDINGS INC COM | $2.7m0.59% | Unchanged |